Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-30

Clinical Trial Update: Predicting Lung Injury From Transfusion in Patients With Liver Disease

View source ↗

Summary

The clinical trial predicting transfusion-related lung injury in patients with liver disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Colorado, Denver | Conditions: Transfusion-related Acute Lung Injury, Chronic Liver Disease | Status: TERMINATED